Merck to file for new use for antibiotic Zerbaxa

The US-based pharma said it will apply to the Food and Drug Administration (FDA) and European Medicines Agency (EMA) to use Zerbaxa at a different dose for adults with either ventilated hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP).